According to a new report published by KD Market Insights, titled, “Fiducial Markers Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global fiducial markers market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The rise, in cancer cases and the increasing need for surgeries, advancements in technology, rising demand for markers due to the improvement in healthcare infrastructure, robotics industry is also experiencing growth which are the major factors augmenting the growth of the global fiducial markers market. The global fiducial markers market is anticipated to grow at a moderate CAGR of 4.5% from 2023 to 2032. The market's revenue surged to $108.4 million in 2022, and it is expected to further accelerate, reaching a notable $168.3 million by 2032.

The rise, in cancer cases and the increasing need for surgeries have led to a demand for precise tumor localization during radiation therapy, are further expected to create ample growth opportunities for the global fiducial markers market during the forecast period i.e., 2023-2032. Moreover, advancements in technology have resulted in the creation of markers that're both biocompatible and cost effective attracting the attention of healthcare providers and patients alike, has propelled market expansion. The robotics industry is also experiencing growth with fiducial markers being utilized for tracking robot positions and orientations, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global fiducial markers market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the high emphasis on cancer research and the increasing prevalence of cancer.

Download Exclusive Sample Report@ https://www.kdmarketinsights.com/sample/7444

According to product, the metal-based markers segment accounted for the largest market share in the fiducial markers market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global fiducial markers market is segmented into product, modality, cancer type, end-users and region. Based on product, the market is bifurcated into metal based markers, polymer-based markers, other fiducial markers. Based on modality, it is classified into CT, CBCT, MRI, ultrasound, radiotherapy. Based on cancer type, it is classified into prostate cancer, lung cancer, breast cancer, gastric cancer, other cancers. Based on end-users, it is classified into hospitals, outpatient facilities, independent radiotherapy centers, cancer research centers.

The global fiducial markers market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Fiducial Markers Market

·        On the basis of product, the metal-based markers segment accounted for the largest market share in the fiducial markers market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

·        On the basis of region, North America accounted for the largest share in the global fiducial markers market in 2022. The region is further projected to continue dominating in the market during the forecast period.

·        On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.

Some of the major fiducial markers companies profiled in the report include CIVCO Radiotherapy, IZI Medical Products, Boston Scientific Corporation, Naslund Medical AB, and IBA. Other players in the market include Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler, Innovative Oncology Solutions, Medtronic, QlRad Inc., JJ-Medtech, and QFIX.

Browse Full Report Along With Facts and Figures@ https://www.kdmarketinsights.com/reports/fiducial-markers-market/7444

Browse Trending Reports:

https://www.kdmarketinsights.com/reports/oligonucleotide-synthesis-market/7455

https://www.kdmarketinsights.com/reports/femtech-market/7454

https://www.kdmarketinsights.com/reports/contrast-media-market/7453

https://www.kdmarketinsights.com/reports/dental-sterilization-market/7452

https://www.kdmarketinsights.com/reports/cholinesterase-activity-testing-market/7451

About KD Market Insights

KD Market Research Company is a reputable and industry-leading market research firm that offers insightful insights, Analytics, and Research Reports for a variety of industries. With an emphasis on providing accurate and actionable market insights and data, our team of experienced research analysts conducts exhaustive research to assist businesses in making informed decisions. Whether you require market forecasts, competitive analysis, or the identification of trends, we offer comprehensive solutions tailored to your specific requirements. Stay ahead of the competition with the dependable market research services of KD Market Research Company.

Contact Us:

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com